Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?

✍ Scribed by Ahmet Emre Eskazan; Teoman Soysal; Yucel Erbilgin; Ugur Ozbek; Burhan Ferhanoglu

• Book ID: 113773432
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 172 KB
• Volume: 35
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/j.leukres.2011.04.025